Drug Shortage Report for COTAZYM ECS 8

Last updated on 2020-02-07 History
Report ID 99638
Drug Identification Number 00502790
Brand name COTAZYM ECS 8
Common or Proper name PANCRELIPASE DELAYED-RELEASE CAPSULES
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) AMYLASE PROTEASE LIPASE
Strength(s) 42000UNIT 45000UNIT 10800UNIT
Dosage form(s) CAPSULE (DELAYED RELEASE)
Route of administration ORAL
Packaging size 500CAP
ATC code A09AA
ATC description DIGESTIVES, INCL ENZYMES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-01-06
Actual start date 2020-01-02
Estimated end date 2020-02-14
Actual end date 2020-02-06
Shortage status Resolved
Updated date 2020-02-07
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-11-25 English Compare
v2 2019-11-25 French Compare
v3 2020-01-02 English Compare
v4 2020-01-03 English Compare
v5 2020-01-20 English Compare
v6 2020-01-20 French Compare
v7 2020-02-06 English Compare
v8 2020-02-06 French Compare
v9 2020-02-07 English Compare